{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:51:29Z","timestamp":1793267489625,"version":"4.5.0"},"reference-count":162,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.diagmicrobio.2014.07.007","type":"journal-article","created":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T01:15:59Z","timestamp":1406769359000},"page":"239-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Dual beta-lactam therapy for serious Gram-negative infections: is it time to revisit?"],"prefix":"10.1016","volume":"80","author":[{"given":"Christine","family":"Rahme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Nicasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Lodise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jac\/8.2.121","article-title":"Comparative activity of mecillinam and ampicillin singly and in combination in the urinary bladder model and experimental mouse model","volume":"8","author":"Anderson","year":"1981","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","article-title":"National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004","volume":"32","year":"2004","journal-title":"Am J Infect Control"},{"issue":"23","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0020","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1161\/CIRCULATIONAHA.105.165564","volume":"111","author":"Baddour","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0025","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1128\/AAC.9.4.701","article-title":"Synergy of mecillinam (FL1060) with penicillins and cephalosporins against Proteus and Klebsiella, with observations on combinations with other antibiotics and against other bacterial species","volume":"9","author":"Baltimore","year":"1976","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0030","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archinte.1985.00360090089015","article-title":"Pseudomonas bacteremia. Retrospective analysis of 410 episodes","volume":"145","author":"Bodey","year":"1985","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0035","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/AAC.34.3.487","article-title":"In vitro activities of combinations of aztreonam, ciprofloxacin, and ceftazidime against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from patients with cystic fibrosis","volume":"34","author":"Bosso","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/AAC.35.4.783","article-title":"Comparative activity of cefepime, alone and in combination, against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients","volume":"35","author":"Bosso","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1086\/421495","article-title":"Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City","volume":"39","author":"Bradford","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1128\/AAC.25.2.283","article-title":"In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli","volume":"25","author":"Buesing","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0060","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1128\/AAC.01420-10","article-title":"Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae","volume":"55","author":"Bulik","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1469-0691.2007.01848.x","article-title":"Extended-spectrum beta-lactamases in North America, 1987-2006","volume":"14","author":"Bush","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0070","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/cc8892","article-title":"Bench-to-bedside review: the role of beta-lactamases in antibiotic-resistant Gram-negative infections","volume":"14","author":"Bush","year":"2010","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0075","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.coph.2012.06.003","article-title":"Improving known classes of antibiotics: an optimistic approach for the future","volume":"12","author":"Bush","year":"2012","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0080","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jac\/11.2.97","article-title":"beta-Lactamase inhibitors in perspective Relationship between Time to Clinical Response and Outcomes among PORT III and IV Hospitalized Patients with Community-Acquired Pneumonia who Received Ceftriaxone and Azithromycin","volume":"11","author":"Bush","year":"1983","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0090","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1128\/AAC.27.4.555","article-title":"Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacae","volume":"27","author":"Bush","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0095","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/AAC.43.6.1379","article-title":"Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents","volume":"43","author":"Carmeli","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0100","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1128\/AAC.47.9.2756-2764.2003","article-title":"Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia","volume":"47","author":"Chamot","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1432-1033.1981.tb06337.x","article-title":"The role of penicillin-proteins in the action of cephalosporins against Escherichia coli and Salmonella typhimurium","volume":"117","author":"Chase","year":"1981","journal-title":"Eur J Biochem"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0110","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/jac\/5.5.549","article-title":"In vitro combination of mecillinam with cephradine or amoxycillin for organisms resistant to single agents","volume":"5","author":"Chattopadhyay","year":"1979","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1607-551X(09)70116-0","article-title":"In vitro activities of antibiotic combinations against clinical isolates of Pseudomonas aeruginosa","volume":"20","author":"Chen","year":"2004","journal-title":"Kaohsiung J Med Sci"},{"issue":"2A","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0002-9343(83)90090-6","article-title":"Enhanced activity of beta-lactam antibiotics with amdinocillin in vitro and in vivo","volume":"75","author":"Cleeland","year":"1983","journal-title":"Am J Med"},{"issue":"47","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0125","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.47.19044-en","article-title":"Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe","volume":"13","author":"Coque","year":"2008","journal-title":"Euro Surveill"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0130","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1128\/AAC.01989-12","article-title":"Human simulated studies of aztreonam and aztreonam-avibactam to evaluate activity against challenging gram-negative organisms, including metallo-\u03b2-lactamase producers","volume":"57","author":"Crandon","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0135","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/AAC.16.5.533","article-title":"Affinities of penicillins and cephalosporins for the penicillin-binding proteins of Escherichia coli K-12 and their antibacterial activity","volume":"16","author":"Curtis","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0140","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/AAC.16.3.325","volume":"16","author":"Curtis","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0145","first-page":"364","article-title":"Combination effect of piperacillin with cefoperazone on staphylococci and gram-negative bacteria","volume":"32","author":"Daschner","year":"1982","journal-title":"Arzneimittelforschung"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0150","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1128\/AAC.00029-07","article-title":"Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae","volume":"51","author":"Davies","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0155","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/AAC.01529-07","article-title":"Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa","volume":"52","author":"Davies","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"5C","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0160","first-page":"101","article-title":"A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients","volume":"80","author":"De Jongh","year":"1986","journal-title":"Am J Med"},{"issue":"6B","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9343(86)90476-6","article-title":"Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside","volume":"80","author":"DeJace","year":"1986","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0170","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1086\/605572","article-title":"Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections","volume":"49","author":"Deresinski","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0175","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF01643616","article-title":"Moxalactam and piperacillin: a study of in vitro characteristics and pharmacokinetics in cancer patients","volume":"13","author":"Drusano","year":"1985","journal-title":"Infection"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0180","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1001\/archinte.1984.00350210078014","article-title":"Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients","volume":"144","author":"Fainstein","year":"1984","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0185","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ijantimicag.2006.12.012","article-title":"Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?","volume":"29","author":"Falagas","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0190","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0195","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1128\/AAC.18.6.906","article-title":"Activity of mecillinam alone and in combination with other beta-lactam antibiotics","volume":"18","author":"Fass","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0200","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/AAC.22.1.167","article-title":"Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolates","volume":"22","author":"Fass","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0205","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1128\/AAC.21.1.188","article-title":"In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas species","volume":"21","author":"Fass","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0210","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/archinte.1985.00360060149023","article-title":"A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients","volume":"145","author":"Feld","year":"1985","journal-title":"Arch Intern Med"},{"issue":"2A","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0215","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0002-9343(83)90103-1","article-title":"Amdinocillin plus cefoxitin versus cefoxitin alone in therapy of mixed soft tissue infections (including diabetic foot infections)","volume":"75","author":"File","year":"1983","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000013861","article-title":"Aminoglycoside antibiotics","volume":"5","author":"Forge","year":"2000","journal-title":"Audiol Neurootol"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0225","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1128\/AAC.00269-09","article-title":"Comparison of methods to test antibiotic combinations against heterogeneous populations of multiresistant Pseudomonas aeruginosa from patients with acute infective exacerbations in cystic fibrosis","volume":"53","author":"Foweraker","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0230","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/cid\/ciq147","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0235","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1128\/AAC.13.3.358","article-title":"Piperacillin, a new penicillin active against many bacteria resistant to other penicillins","volume":"13","author":"Fu","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0240","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1097\/01.CCM.0000275389.31974.22","article-title":"Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy","volume":"35","author":"Garnacho-Montero","year":"2007","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0245","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1128\/AAC.21.6.963","article-title":"Antagonism of carbenicillin and cefamandole by cefoxitin in treatment of experimental infections in mice","volume":"21","author":"Goering","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0250","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1128\/AAC.23.1.91","article-title":"Characterization of beta-lactamase induction in Enterobacter cloacae","volume":"23","author":"Gootz","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0255","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/AAC.9.4.589","article-title":"In vivo synergy between 6 beta-amidinopenicillanic acid derivatives and other antibiotics","volume":"9","author":"Grunberg","year":"1976","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0260","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0002-9343(78)90188-2","article-title":"Granulocytopenia in hospitalized patients. II. A prospective comparison of two antibiotic regimens in the empiric therapy of febrile patients","volume":"64","author":"Gurwith","year":"1978","journal-title":"Am J Med"},{"issue":"5C","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0265","first-page":"21","article-title":"Synergism and antagonism in double beta-lactam antibiotic combinations","volume":"80","author":"Gutmann","year":"1986","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0270","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/jac\/dkt056","article-title":"Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs","volume":"68","author":"Hagihara","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0275","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7164\/antibiotics.37.394","article-title":"Studies on the mechanism of action of imipenem (N-formimidoylthienamycin) in vitro: binding to the penicillin-binding proteins (PBPs) in Escherichia coli and Pseudomonas aeruginosa, and inhibition of enzyme activities due to the PBPs in E. coli","volume":"37","author":"Hashizume","year":"1984","journal-title":"J Antibiot (Tokyo)"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0280","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jac\/12.2.119","article-title":"Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus","volume":"12","author":"Hayes","year":"1983","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0285","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/01.CCM.0B013E31816203D6","article-title":"Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia","volume":"36","author":"Heyland","year":"2008","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0290","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0002-9343(89)80611-4","article-title":"Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients","volume":"87","author":"Hilf","year":"1989","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0295","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.diagmicrobio.2005.04.004","article-title":"Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998\u20132002)","volume":"52","author":"Hirakata","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0300","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/AAC.02411-12","article-title":"Characterization of porin expression in Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems","volume":"57","author":"Hong","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0305","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1177\/106002809102500912","article-title":"Overview of synergy with reference to double beta-lactam combinations","volume":"25","author":"Hopefl","year":"1991","journal-title":"DICP"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0310","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4161\/viru.19700","article-title":"Acinetobacter baumannii: an emerging opportunistic pathogen","volume":"3","author":"Howard","year":"2012","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0315","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.118.1.146","article-title":"The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting","volume":"118","author":"Ibrahim","year":"2000","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0320","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC beta-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0325","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/AAC.28.6.735","article-title":"Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats","volume":"28","author":"Johnson","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0330","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF00366445","article-title":"Double beta-lactam regimen compared to an aminoglycoside\/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients","volume":"1","author":"Joshi","year":"1993","journal-title":"Support Care Cancer"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0335","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/377200","article-title":"Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome","volume":"37","author":"Kang","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0340","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/AAC.43.3.623","article-title":"Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria","volume":"43","author":"Kashuba","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0350","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jama.1974.03230140019004","article-title":"Gram-negative infections in cancer. Study of empiric therapy comparing carbenicillin-cephalothin with and without gentamicin","volume":"227","author":"Klastersky","year":"1974","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0355","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/AAC.7.5.640","article-title":"Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin, and cephalothin-tobramycin","volume":"7","author":"Klastersky","year":"1975","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0345","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/AAC.18.3.437","article-title":"Carbenicillin plus cefazolin with or without mecillinam as an early treatment of bacteremia caused by gram-negative organisms: randomized double-blind study","volume":"18","author":"Klastersky","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2014.07.007_bb1000","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1128\/AAC.43.5.1170","article-title":"In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates","volume":"43","author":"Kohler","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0360","doi-asserted-by":"crossref","first-page":"298","DOI":"10.7326\/0003-4819-134-4-200102200-00014","article-title":"Antibiotic resistance in the intensive care unit","volume":"134","author":"Kollef","year":"2001","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb1005","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1128\/AAC.17.3.316","article-title":"Moxalactam (6059-S), a new 1-oxa-beta-lactam: binding affinity for penicillin-binding proteins of Escherichia coli K-12","volume":"17","author":"Komatsu","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0365","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.7164\/antibiotics.34.1327","article-title":"Effect of combination of cefsulodin and beta-lactam antibiotics against Serratia marcescens","volume":"34","author":"Kondo","year":"1981","journal-title":"J Antibiot (Tokyo)"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0370","doi-asserted-by":"crossref","first-page":"727","DOI":"10.7164\/antibiotics.34.727","article-title":"Effect of combination of cefsulodin and mecillinam","volume":"34","author":"Kondo","year":"1981","journal-title":"J Antibiot (Tokyo)"},{"issue":"2A","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0375","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0002-9343(83)90091-8","article-title":"Morphologic changes produced by amdinocillin alone and in combination with beta-lactam antibiotics: in vitro and in vivo","volume":"75","author":"Kramer","year":"1983","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0380","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1128\/AAC.19.4.634","article-title":"In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics","volume":"19","author":"Kuck","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0385","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/AAC.20.2.239","article-title":"Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens","volume":"20","author":"Kurtz","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb1010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1128\/AAC.26.3.335","article-title":"Affinity of temocillin for Escherichia coli K-12 penicillin-binding proteins","volume":"26","author":"Labia","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb1015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/15.1.9","article-title":"Binding of latamoxef (moxalactam) and its decarboxylated derivative to Escherichia coli and Pseudomonas aeruginosa penicillin-binding proteins","volume":"15","author":"Labia","year":"1985","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb1020","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF01640897","article-title":"Comparative study of the serum bactericidal activity of cefoperazone alone and in combination with amikacin or mezlocillin against gram-negative bacilli and Staphylococcus aureus","volume":"12","author":"Lagast","year":"1984","journal-title":"Infection"},{"issue":"2A","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0390","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0002-9343(83)90105-5","article-title":"Amdinocillin: use alone or in combination with cefoxitin or carbenicillin-ticarcillin","volume":"75","author":"Lawson","year":"1983","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0395","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000441-198401000-00004","article-title":"A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies","volume":"287","author":"Lawson","year":"1984","journal-title":"Am J Med Sci"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0400","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/AAC.42.7.1610","article-title":"Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa","volume":"42","author":"Lister","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0405","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccc.2010.11.003","article-title":"Pharmacokinetics and pharmacodynamics: optimal antimicrobial therapy in the intensive care unit","volume":"27","author":"Lodise","year":"2011","journal-title":"Crit Care Clin"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0415","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1128\/AAC.00338-07","article-title":"Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection","volume":"51","author":"Lodise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0425","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1128\/AAC.35.1.104","article-title":"In vitro antibacterial activity of KP-736, a new cephem antibiotic","volume":"35","author":"Maejima","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0430","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0435","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000238180","article-title":"In vitro activity of cefoxitin, alone and in combination with aminoglycoside or other beta-lactam antibiotics against common gram-negative pathogens","volume":"29","author":"Markowitz","year":"1983","journal-title":"Chemotherapy"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0440","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijantimicag.2011.04.022","article-title":"Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009","volume":"38","author":"Master","year":"2011","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0445","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1128\/AAC.18.1.195","article-title":"Affinity of cefoperazone for penicillin-binding proteins","volume":"18","author":"Matsubara","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2014.07.007_bb1025","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.7164\/antibiotics.31.1292","article-title":"Enzymatic studies on the mechanism of action of cefoxitin. Correlation between the affinities of cefoxitin to penicillin-binding proteins and its rates of inhibition of the respective penicillin-sensitive reactions in E. coli","volume":"31","author":"Matsuhashi","year":"1978","journal-title":"J Antibiot (Tokyo)"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0450","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1128\/AAC.36.12.2741","article-title":"Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model","volume":"36","author":"McGrath","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"issue":"2 Suppl","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0455","first-page":"403","article-title":"Aztreonam plus cefazolin: a double beta-lactam combination as empirical therapy in febrile cancer patients with or without granulocytopenia","volume":"6","author":"Menichetti","year":"1987","journal-title":"Chemioterapia"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0460","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/BF01642106","article-title":"Ceftriaxone versus aztreonam plus cefazolin for infections in cancer patients with adequate neutrophil counts","volume":"18","author":"Menichetti","year":"1990","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0470","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1128\/AAC.49.4.1306-1311.2005","article-title":"Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment","volume":"49","author":"Micek","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0475","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/1097-0142(197208)30:2<573::AID-CNCR2820300238>3.0.CO;2-O","article-title":"Antibiotic combinations for infections in neutropenic patients. Evaluation of carbenicillin plus either cephalothin or kanamycin","volume":"30","author":"Middleman","year":"1972","journal-title":"Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0480","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00003495-198100221-00005","article-title":"Comparison of the activity of cefoperazone, cefuroxime and cefoxitin against Gram-negative bacilli and synergy studies with cefoperazone and ticarcillin","volume":"22","author":"Miles","year":"1981","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0485","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/AAC.18.3.382","article-title":"Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae","volume":"18","author":"Minami","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0490","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/infdis\/140.4.639","article-title":"Antimicrobial synergism\u2014an elusive concept","volume":"140","author":"Moellering","year":"1979","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0495","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1128\/AAC.26.2.256","article-title":"In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics","volume":"26","author":"Moody","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0500","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1007\/BF02561666","article-title":"Combination therapy as a tool to prevent emergence of bacterial resistance","volume":"27","author":"Mouton","year":"1999","journal-title":"Infection"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0505","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1128\/AAC.00296-10","article-title":"Affinity of the new cephalosporin CXA-101 to penicillin-binding proteins of Pseudomonas aeruginosa","volume":"54","author":"Moya","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0510","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1592\/phco.19.16.1252.30876","article-title":"Pharmacodynamic characterization of nephrotoxicity associated with once-daily aminoglycoside","volume":"19","author":"Murry","year":"1999","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0515","first-page":"743","article-title":"Drug-induced nephrotoxicity","volume":"78","author":"Naughton","year":"2008","journal-title":"Am Fam Physician"},{"issue":"Suppl C","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0520","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jac\/10.suppl_C.63","article-title":"Combination of ceftizoxime with azlocillin, mezlocillin, piperacillin and ticarcillin","volume":"10","author":"Neu","year":"1982","journal-title":"J Antimicrob Chemother"},{"issue":"2A","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0525","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0002-9343(83)90089-X","article-title":"Penicillin-binding proteins and role of amdinocillin in causing bacterial cell death","volume":"75","author":"Neu","year":"1983","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0530","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/AAC.13.5.813","article-title":"Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins","volume":"13","author":"Neu","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0535","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1592\/phco.28.2.235","article-title":"The current state of multidrug-resistant gram-negative bacilli in North America","volume":"28","author":"Nicasio","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0540","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1432-1033.1979.tb02031.x","article-title":"Comparative studies of penicillin-binding proteins in Pseudomonas aeruginosa and Escherichia coli","volume":"100","author":"Noguchi","year":"1979","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.diagmicrobio.2014.07.007_bb0545","doi-asserted-by":"crossref","DOI":"10.3201\/eid1710.110655","article-title":"Global spread of carbapenemase-producing Enterobacteriaceae","author":"Nordmann","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0550","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/AAC.15.1.20","article-title":"SCE-963, a new potent cephalosporin with high affinity for penicillin-binding proteins 1 and 3 of Escherichia coli","volume":"15","author":"Nozaki","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0555","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: Clinical Practice Guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"7399","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0565","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bmj.326.7399.1111","article-title":"Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis","volume":"326","author":"Paul","year":"2003","journal-title":"BMJ"},{"issue":"7441","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0560","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/bmj.38028.520995.63","article-title":"Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials","volume":"328","author":"Paul","year":"2004","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0570","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/AAC.25.5.545","article-title":"Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model","volume":"25","author":"Peterson","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0575","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1128\/AAC.35.11.2312","article-title":"Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329","volume":"35","author":"Pucci","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"issue":"1A","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0580","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0002-9343(88)90173-8","article-title":"Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients","volume":"85","author":"Rotstein","year":"1988","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0585","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/jac\/25.4.679","article-title":"Nephrotoxicity of vancomycin, alone and with an aminoglycoside","volume":"25","author":"Rybak","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0595","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0732-8893(03)00158-5","article-title":"Contemporary in vitro synergy rates for aztreonam combined with newer fluoroquinolones and beta-lactams tested against gram-negative bacilli","volume":"47","author":"Sader","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0590","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1128\/AAC.02436-12","article-title":"Antimicrobial activity of ceftaroline-avibactam tested against clinical isolates collected from U.S. Medical Centers in 2010\u20132011","volume":"57","author":"Sader","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0600","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(04)01108-9","article-title":"Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis","volume":"4","author":"Safdar","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0605","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/infdis\/151.3.399","article-title":"Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications","volume":"151","author":"Sanders","year":"1985","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0615","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/clinids\/10.4.830","article-title":"Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins","volume":"10","author":"Sanders","year":"1988","journal-title":"Rev Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0610","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1128\/AAC.21.6.968","article-title":"In vitro antagonism of beta-lactam antibiotics by cefoxitin","volume":"21","author":"Sanders","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0620","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF01816731","article-title":"Mecillinam alone and in combination with ampicillin or moxalactam in experimental Escherichia coli meningitis","volume":"10","author":"Schaad","year":"1982","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0625","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1128\/AAC.16.3.271","article-title":"Mecillinam-ampicillin synergism in experimental Enterobacteriaceae meningitis","volume":"16","author":"Scheld","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0635","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1128\/AAC.10.5.837","article-title":"Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients","volume":"10","author":"Schimpff","year":"1976","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0630","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/infdis\/137.1.14","article-title":"Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group","volume":"137","author":"Schimpff","year":"1978","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0640","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1128\/AAC.21.6.939","article-title":"Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis","volume":"21","author":"Scribner","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0645","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1128\/AAC.19.3.393","article-title":"Differences between ceftizoxime and its stereoisomer in antibacterial activity and affinity for penicillin-binding proteins","volume":"19","author":"Shigi","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0650","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/jac\/19.6.807","article-title":"Pseudomonas peritonitis in neutropenic rats treated with amikacin, ceftazidime and ticarcillin, alone and in combination","volume":"19","author":"Shyu","year":"1987","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0655","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0924-8579(02)00269-8","article-title":"In vitro activity of beta-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa","volume":"21","author":"Song","year":"2003","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 5","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0660","first-page":"S397","article-title":"Combating antimicrobial resistance: policy recommendations to save lives","volume":"52","author":"Spellberg","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"Suppl B","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0665","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/3.suppl_B.13","article-title":"The mechanism of action of mecillinam","volume":"3","author":"Spratt","year":"1977","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0670","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/JB.131.1.293-305.1977","article-title":"Temperature-sensitive cell division mutants of Escherichia coli with thermolabile penicillin-binding proteins","volume":"131","author":"Spratt","year":"1977","journal-title":"J Bacteriol"},{"issue":"5500","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0675","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/254516a0","article-title":"Penicillin-binding proteins and cell shape in E. coli","volume":"254","author":"Spratt","year":"1975","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0680","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1128\/AAC.25.2.212","article-title":"In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients","volume":"25","author":"Stutman","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0685","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7164\/antibiotics.43.314","article-title":"Comparison of two carbapenems, SM-7338 and imipenem: affinities for penicillin-binding proteins and morphological changes","volume":"43","author":"Sumita","year":"1990","journal-title":"J Antibiot (Tokyo)"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0690","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1073\/pnas.75.2.664","article-title":"On the process of cellular division in Escherichia coli: a series of mutants of E. coli altered in the penicillin-binding proteins","volume":"75","author":"Suzuki","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0695","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.1073\/pnas.74.12.5472","article-title":"Thermosensitive mutation in Escherichia coli simultaneously causing defects in penicillin-binding protein-1Bs and in enzyme activity for peptidoglycan synthesis in vitro","volume":"74","author":"Tamaki","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0700","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0705","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000238716","article-title":"Therapeutic efficacy of the combination of aztreonam with cefotaxime in the treatment of severe nosocomial pneumonia. Comparative study against amikacin combined with cefotaxime","volume":"35","author":"Torres","year":"1989","journal-title":"Chemotherapy"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0710","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1592\/phco.31.6.598","article-title":"Monotherapy or combination therapy? The Pseudomonas aeruginosa conundrum","volume":"31","author":"Traugott","year":"2011","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0715","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","article-title":"Practice guidelines for the management of bacterial meningitis","volume":"39","author":"Tunkel","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0720","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1128\/AAC.8.3.271","article-title":"Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: bactericidal action and synergy in vitro","volume":"8","author":"Tybring","year":"1975","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0725","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1086\/588048","article-title":"Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities","volume":"46","author":"Urban","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0730","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/inf.1983.15.issue-1.15","article-title":"The antibacterial activity of combinations of mecillinam and ampicillin in vitro and in normal and granulopenic mice","volume":"15","author":"van der Voet","year":"1983","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0735","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/AAC.26.2.224","article-title":"Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, against Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa","volume":"26","author":"Van Laethem","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0740","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/AAC.25.1.142","article-title":"Effect of temocillin in combination with other beta-lactam antibiotics","volume":"25","author":"Verbist","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0745","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1128\/AAC.01452-08","article-title":"In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa","volume":"53","author":"Vidaillac","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.07.007_bb0750","series-title":"WHO Global Strategy for Containment of Antimicrobial Resistance","author":"World Health Organization (WHO)","year":"2001"},{"key":"10.1016\/j.diagmicrobio.2014.07.007_bb0755","series-title":"The evolving threat of antimicrobial resistance options for action","author":"World Health Organization (WHO)","year":"2012"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0760","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0002-9343(84)90100-1","article-title":"Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients","volume":"77","author":"Winston","year":"1984","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0765","doi-asserted-by":"crossref","first-page":"849","DOI":"10.7326\/0003-4819-115-11-849","article-title":"Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone","volume":"115","author":"Winston","year":"1991","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0770","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ijantimicag.2013.02.015","article-title":"Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae","volume":"41","author":"Wiskirchen","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0775","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1128\/AAC.26.4.519","article-title":"Effect of aztreonam in combination with azlocillin or piperacillin on Pseudomonas aeruginosa","volume":"26","author":"Wu","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0780","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/35.1.75","article-title":"Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases","volume":"35","author":"Yang","year":"1995","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0785","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40265-013-0013-7","article-title":"Ceftazidime-avibactam: a novel cephalosporin\/beta-lactamase inhibitor combination","volume":"73","author":"Zhanel","year":"2013","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0790","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1128\/AAC.18.1.94","article-title":"Penetration of beta-lactam antibiotics into their target enzymes in Pseudomonas aeruginosa: comparison of a highly sensitive mutant with its parent strain","volume":"18","author":"Zimmermann","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.07.007_bb0795","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1128\/AAC.20.4.463","article-title":"In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureus","volume":"20","author":"Zinner","year":"1981","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889314002892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889314002892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T05:30:41Z","timestamp":1649827841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889314002892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":162,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0732889314002892"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.07.007","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual beta-lactam therapy for serious Gram-negative infections: is it time to revisit?","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}